K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 804.00
-9.00 (-1.11%)
Sep 16, 2026, 2:56 PM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 9.45 billion as of September 15, 2026. Its market cap has increased by 23.75% in one year.
Market Cap
9.45B
Enterprise Value
8.72B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
804.00
ChartMarket Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 9.45B, a decrease of -13.68%. That is a compound annual growth rate of -4.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 9.45B | 23.37% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 11.41B |
| Immuno-Biological Laboratories | 10.79B |
| Kubota Pharmaceutical Holdings | 10.70B |
| Carna Biosciences | 9.07B |
| Nano Holdings | 9.03B |
| OncoTherapy Science | 8.98B |
| CellSeed | 8.79B |
| J-Pharma | 8.49B |